The underlying pathophysiology of T1D involves the autoimmune destruction of insulin‐secreting pancreatic β‐cells, resulting in endogenous insulin deficiency and a lifelong dependence on exogenous insulin replacement therapy.2, 3. This evidence concerns the gene INS and type 1 diabetes mellitus.